Related Experiment Video
Updated: Jul 7, 2026

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Chronic hypoglycemic effect of Malmea depressa root on n5-streptozotocin diabetic rats
Adolfo Andrade-Cetto1, Eddy Martínez-Zurita, Ana Soto-Constantino
1Lab. de Etnofarmacología, Facultad de Ciencias, Universidad Nacional Autónoma de México, 04510 México, D.F., Mexico. aac@hp.fciencias.unam.mx
Abstract:
The root of the "Elemuy" tree (Malmea depressa) is highly used in south east Mexico by the Mayan communities to treat type 2 diabetes. The long-term hypoglycemic effect (HbA1c) and the stimulation of insulin secretion resulting from the treatment with butanolic extract was studied using (n5-stz)-induced diabetic rats. We show that after 30 days of daily administration of 10 mg/kg of the butanolic extract, the glucose levels as well as the (HbA1c) levels were lower compared to the control group. This effect was also observed after 45 days of treatment, leading to the conclusion that the effects of chronic butanolic extract treatment are comparable to treatment with the standard drug Bieuglucon. In an acute experiment, we found that a single administration of the extract at a dose of 50 mg/kg stimulates insulin release, which is similar to the result seen with Tolbutamide administration. The new compound, 3-(3-hydroxy-2,4,5-trimethoxyphenyl) propane-1,2 diol, was isolated from the active fraction of the butanolic extract. The results presented here support the utility of the traditional use of the root and suggest that the active fraction of the plant extract could be developed as a phytomedicine.
Related Concept Videos
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Oral Hypoglycemic Agents: Glinides
Hypoglycemia
Diabetes Mellitus: Type 2 and Gestational
